About Tempus
Tempus is a company based in Chicago (United States) founded in 2015 by Eric Lefkofsky. It operates as a AI-as-a-Service, Data-as-a-Service, and Professional Services. Tempus has raised $760 million across 8 funding rounds from investors including Google, T. Rowe Price and Franklin Templeton. The company has 2,400 employees as of December 31, 2024. Tempus has completed 5 acquisitions, including Ambry Genetics, Deep 6 AI and Highline SCIENCES. Tempus offers products and services including Tempus One, Tempus Lens, Tempus xM, and Tempus Pixel. Tempus operates in a competitive market with competitors including Personalis, CancerIQ, Perthera, LinkDoc and Trapelo, among others.
- Headquarter Chicago, United States
- Employees 2400 as on 31 Dec, 2024
- Founders Eric Lefkofsky
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tempus Ai, Inc.
-
Annual Revenue
$693.4 M30.38as on Dec 31, 2024
-
Net Profit
$-705.81 M-229.64as on Dec 31, 2024
-
EBITDA
$-651.14 M-299.1as on Dec 31, 2024
-
Total Equity Funding
$760 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
Google
& 7 more
-
Employee Count
2400
as on Dec 31, 2024
-
Investments & Acquisitions
Ambry Genetics
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tempus
Tempus is a publicly listed company on the NASDAQ with ticker symbol TEM in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Tempus
Tempus offers a comprehensive portfolio of products and services, including Tempus One, Tempus Lens, Tempus xM, and Tempus Pixel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI assistant for healthcare providers and researchers.
Platform for accessing multimodal real-world data analysis.
Assay for monitoring immunotherapy response in cancers.
Imaging solutions for therapy response evaluation purposes.
Unlock access to complete
Unlock access to complete
Leadership Team
136 people
Software Development Team
114 people
Operations Team
100 people
Sales and Marketing
47 people
Senior Team
34 people
Data Analysis and Operations Team
25 people
Product Management Team
14 people
Human Resources and Administration
11 people
Unlock access to complete
Funding Insights of Tempus
Tempus has successfully raised a total of $760M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(22 Sep 2017)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series G - Tempus | Valuation |
investors |
|
| Oct, 2022 | Amount | Debt – Conventional - Tempus | Valuation |
investors |
|
| Dec, 2020 | Amount | Series G - Tempus | Valuation |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tempus
Tempus has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Google, T. Rowe Price and Franklin Templeton. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Revolution is recognized as a D.C.-based investment firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tempus
Tempus has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Ambry Genetics, Deep 6 AI and Highline SCIENCES. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CRO focused on clinical development services for oncology drugs
|
2018 | ||||
|
AI-enabled tools for computational pathology and cancer diagnostics are provided.
|
2018 | ||||
|
AI enabled solutions for clinical trials
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Tempus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tempus Comparisons
Competitors of Tempus
Tempus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Personalis, CancerIQ, Perthera, LinkDoc and Trapelo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
CancerIQ is focused on precision cancer prevention and care.
|
|
| domain | founded_year | HQ Location |
Molecular cancer profiling is conducted via genomics and proteomics.
|
|
| domain | founded_year | HQ Location |
Oncology-focused database is provided for cancer analytics.
|
|
| domain | founded_year | HQ Location |
Precision medicine platform is provided for oncologists' decision support.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tempus
Frequently Asked Questions about Tempus
When was Tempus founded?
Tempus was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Tempus located?
Tempus is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of Tempus?
Eric Lefkofsky is the current CEO of Tempus. They have also founded this company.
Is Tempus a funded company?
Tempus is a funded company, having raised a total of $760M across 8 funding rounds to date. The company's 1st funding round was a Series G of $200M, raised on Sep 22, 2017.
How many employees does Tempus have?
As of Dec 31, 2024, the latest employee count at Tempus is 2,400.
What is the annual revenue of Tempus?
Annual revenue of Tempus is $693.4M as on Dec 31, 2024.
What does Tempus do?
Tempus is engaged in developing AI-enabled precision medicine solutions for healthcare providers, life sciences, and patients. The company operates in sectors such as oncology, neurology, psychiatry, cardiology, and radiology. Solutions offered include genomic profiling, clinical trial matching, real-world data analysis, and diagnostic imaging. Through extensive research and partnerships, Tempus is committed to accelerating personalized patient care and transforming drug development for pharmaceutical companies. Its technology integrates with electronic health records to enhance workflow and close care gaps.
Who are the top competitors of Tempus?
Tempus's top competitors include Personalis, CancerIQ and Perthera.
What products or services does Tempus offer?
Tempus offers Tempus One, Tempus Lens, Tempus xM, and Tempus Pixel.
Is Tempus publicly traded?
Yes, Tempus is publicly traded on NASDAQ under the ticker symbol TEM.
How many acquisitions has Tempus made?
Tempus has made 5 acquisitions, including Ambry Genetics, Deep 6 AI, and Highline SCIENCES.
Who are Tempus's investors?
Tempus has 8 investors. Key investors include Google, T. Rowe Price, Franklin Templeton, Baillie Gifford, and Novo Holdings.
What is Tempus's ticker symbol?
The ticker symbol of Tempus is TEM on NASDAQ.
What is Tempus's valuation?
The valuation of Tempus is $8.1B as of Dec 2020.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.